Strelia is thrilled to have assisted Keensight Capital, in the Luxembourg legal aspects of the combination between Biovian and 3P Biopharmaceuticals, which led to the creation of 3PBIOVIAN.
This combination will boost 3PBIOVIAN's position in the field of biologics Contract Development and Manufacturing Organizations (CDMOs). We congratulate the Keensight team and all parties involved and would like to extend our gratitude to Paul Hastings Paris, Castrén & Snellman and Garrigues for the excellent cooperation.
Great teamwork of Corporate and M&A team members from Strelia Luxembourg: Vanessa Schmitt (Partner) and Giada Mognol (Associate) with the help of Michael Meylan (Partner) and Estelle Schul (Senior Associate).